3rd Biennial International Symposium on Ocular Regeneration

October 11, 2018 | Boston

Ocular Regeneration Symposium 2018

Registration is Closed

On-site registration will not be available

Tissue Engineering and The Eye

Join clinicians and basic scientists from multiple disciplines who are working to accelerate cures and restore vision in patients with degenerative eye diseases, such as age-related macular degeneration, glaucoma, cornea and dry eye disease, and inherited retinal disorders. The Ocular Regeneration Symposium will facilitate engaging discussions on the latest advances in tissue engineering and potential applications to eye diseases.

Keynote Speaker

This year’s keynote speaker is Robert Langer, ScD, the David H. Koch Institute Professor, Massachusetts Institute of Technology. A major focus of his research includes the use of polymers for the controlled-delivery of drugs.

Invited Speakers

  • Jennifer Elisseeff, PhD, John Hopkins University
  • John Giebel, DSc, MD, AGAF, Yale School of Medicine
  • Kapil Bharti, PhD, National Eye Institute
  • Jeff Karp, PhD, Brigham and Women’s Hospital
  • Erin Lavik, MS, ScDUniversity of Maryland Baltimore County
  • David Mooney, PhD, Wyss Institute for Biologically Inspired Engineering at Harvard University
  • Molly Shoichet, PhD, University of Toronto
  • Budd Tucker, PhD, University of Iowa 

This event is hosted by the Harvard Ophthalmology Ocular Regenerative Medicine Institute, in partnership with the 5th Biennial International Symposium on AMD.

Co-Directors of the symposium include Michael Young, PhD, and Demetrios Vavvas, MD, PhD
 

 

Major Sponsors

National Institutes of Health (Travel Awards)
RxGen

Additional Sponsors

Alcon
Biogen
Catalyst Biosciences

Gorin Foundation
ReNeuron

 

Thursday, October 11*

Starr Center
185 Cambridge Street, 2nd Floor

Time Title Speaker
BREAKFAST (7:00am)
8:00am Opening remarks and presentation of Travel Awards Demetrios Vavvas, MD, PhD, and Michael Young, PhD
8:15am Vasoelasticity and regeneration David Mooney, PhD
Robert P. Pinkas Family Professor of Bioengineering, Core Faculty Member, Wyss Institute for Biologically Inspired Engineering at Harvard University
8:45am

Cornea mimetic biomaterials and manipulating the ocular surface

Jennifer Elisseeff, PhD
Professor, Wilmer Eye Institute and Department of Biomedical Engineering, Johns Hopkins University
9:15am Induced pluripotent stem cell derived 3D engineered eye tissues to restore blinding Eye diseases Kapil Bharti Earl Stadtman, PhD
Tenure-Track Investigator, National Eye Institute; Adjunct Group Leader, National Center for Advancing Translational Sciences, National Institutes of Health
9:45am Panel 1 Moderator: Eleftherios Paschalis Ilios, PhD
Instructor in Ophthalmology, Harvard Medical School (HMS)
BREAK (10:15am)
10:30am Engineered outer retinal grafts for autologous cell replacement Budd Tucker, PhD
Stephen A. Wynn Associate Professor of Regenerative Medicine, University of Iowa
11:00am Hydrogel-mediated cell transplantation promotes vision repair in animal models of blindness Molly Shoichet, PhD
Professor, University of Toronto
12:00pm Panel 2 Moderator: Ula Jurkunas, MD
Associate Professor of Ophthalmology, HMS
LUNCH (12:00-1:30pm)
1:00pm Poster Session  
1:30pm 3D Bioprinting as related to tissue engineering John Geibel, DSc, MD, AGAF
Professor of Surgery (Gastrointestinal) and of Cellular and Molecular Physiology, Yale School of Medicine
2:00pm  Tools for accelerated medical innovation Jeff Karp, PhD
Associate Professor, Brigham and Women's Hospital
2:30pm Engineering materials for models and therapies in the eye Erin Lavik, MS, ScD
Professor of Chemical, Biochemical, and Environmental Engineering, University of Maryland Baltimore County
3:00pm Panel 3 Moderator: Bruce Ksander, PhD
Associate Professor of Ophthalmology, HMS
BREAK (3:30pm)
3:45pm Introduction to Keynote Speaker Joan W. Miller, MD
Chair, Harvard Ophthalmology
Chief of Ophthalmology, Mass. Eye and Ear and Mass General Hospital
4:00pm Keynote Speaker:
Biomaterials and biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering
Robert Langer
David H. Koch Institute Professor, Massachusetts Institute of Technology
RECEPTION (5:30 pm)
Mass. Eye and Ear
243 Charles Street, 7th floor

*Subject to changes